Jump to main content
Jump to site search

Issue 10, 2009
Previous Article Next Article

Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors

Author affiliations

Abstract

Covering: up to 2009

A number of small-molecule natural products have been shown to inhibit the activity of histone deacetylases (HDACs). These enzymes catalyze the hydrolysis of N-acetyl lysine residues of the histone proteins that package chromosomal DNA and thereby play a vital role in mediating gene expression. HDAC inhibitors (HDACi) are potent cytotoxic agents with significant potential as anticancer therapeutics and it is currently thought that their selective activity on members of specific subclasses of the eighteen known human HDAC isoforms is important to this activity and to moderation of their toxicity. Herein, we discuss both linear and cyclic HDACi, as well as selected synthetically derived analogs.

Graphical abstract: Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors

Back to tab navigation

Article information


Submitted
04 Apr 2009
First published
03 Aug 2009

Nat. Prod. Rep., 2009,26, 1293-1320
Article type
Review Article

Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors

T. L. Newkirk, A. A. Bowers and R. M. Williams, Nat. Prod. Rep., 2009, 26, 1293
DOI: 10.1039/B817886K

Social activity

Search articles by author

Spotlight

Advertisements